AEHR stock is currently trading at $12.90, significantly down from its highs due to weak Q2 FY2025 results, including a 37% YoY revenue drop and challenges in the silicon carbide market until 2026. Bulls argue that diversification into AI and gallium nitride markets, along with a maintained FY2025 revenue guidance of $70M, positions AEHR for long-term growth. However, near-term risks persist, making it a speculative play for patient investors.